Kirsten Fischer
0009-0006-6169-9152
2 papers found
Refreshing results…
Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial
Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia
Missing publications? Search for publications with a matching author name.